Traders should review the full Form 20-F filing on the SEC website to assess actual financial performance; the absence of data in the press release limits immediate trading implications.
MDWD drugs
MDWD drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 6 $17.03entry
- T+1 · 8mo ago +2.70%α +1.85% · $17.49
- T+5 · 8mo ago −2.64%α −1.11% · $16.58
- T+20 · 8mo ago −2.99%α −0.95% · $16.52
- T+60 · 6mo ago −18.85%α −31.63% · $13.82
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
MediWound Ltd. filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, disclosing audited financial results. The press release provides no financial figures or operational highlights, only announcing the filing's availability.
Key Facts
- MediWound filed its annual report on Form 20-F for fiscal year 2025.
- No financial results, guidance, or operational metrics were disclosed in the press release.
- The report is available via the SEC website and the company’s investor relations page.
Financial Impact
Unknown, no financial data provided in press release
Risk Factors
- Lack of disclosed financials in the press release may indicate underwhelming results.
- Delayed or minimal disclosure can precede negative market reaction if underlying results are weak.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3250703 |
Track record
13 reports on MDWD
6 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +20.80% at T+60 after the Mar 5, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $12.90 Now $13.55 +5.04% settles Nov 20
- Nov 12, 20264d ago 6-K Bearish 6/10 No price data
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $12.97 Now $13.55 −4.47% settles Nov 19
- Nov 5, 202611d ago 6-K Bearish 6/10 Entry $13.33 to $12.97 Now $13.55 −1.65% ▲ +2.70% +5.99% vs SPY
- Nov 5, 202611d ago 424B5 Bearish 5/10 Entry $13.33 to $12.97 Now $13.55 −1.65% ▲ +2.70% +5.99% vs SPY
- Nov 3, 202613d ago 424B5 Bearish 5/10 Entry $14.20 to $13.82 Now $13.55 +4.58% ▲ +2.68% +1.76% vs SPY
- Sep 22, 20267w ago Press Release Bullish 4/10 Entry $13.95 to $13.80 Now $13.55 −2.87% ▼ −1.08% +0.11% vs SPY
- Jun 2, 202623w ago Insider Cluster Bullish 4/10 Entry $13.76 to $14.30 Now $13.55 −1.53% ▲ +3.92% +6.89% vs SPY
- May 27, 202624w ago Press Release Bearish 5/10 Entry $14.33 to $13.73 Now $13.55 +5.44% ▲ +4.19% +4.66% vs SPY
- May 7, 202627w ago Press Release Neutral 1/10 Entry $17.27 to $16.25 Now $13.55 −21.54% ▼ −5.91% −7.41% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers